APA (7th ed.) Citation

Iby, J., Coulibaly, L., Hollaus, M., Yeghiazaryan, L., Schmidt-Erfurth, U., Bühl, W., & Sacu, S. (2026). Efficacy of a single dose switch from aflibercept to ranibizumab in the treatment of neovascular age-related macular degeneration. PLoS ONE, 21(3), 1. https://doi.org/10.1371/journal.pone.0342927

Chicago Style (17th ed.) Citation

Iby, Johannes, Leonard Coulibaly, Marlene Hollaus, Lusine Yeghiazaryan, Ursula Schmidt-Erfurth, Wolf Bühl, and Stefan Sacu. "Efficacy of a Single Dose Switch from Aflibercept to Ranibizumab in the Treatment of Neovascular Age-related Macular Degeneration." PLoS ONE 21, no. 3 (2026): 1. https://doi.org/10.1371/journal.pone.0342927.

MLA (9th ed.) Citation

Iby, Johannes, et al. "Efficacy of a Single Dose Switch from Aflibercept to Ranibizumab in the Treatment of Neovascular Age-related Macular Degeneration." PLoS ONE, vol. 21, no. 3, 2026, p. 1, https://doi.org/10.1371/journal.pone.0342927.